QIAGEN N.V. (QIA) Discloses Goldman Sachs 3.41% Voting Rights

QIAGEN N.V. reported an AFM notification that Goldman Sachs Group holds 3.41% of voting rights and capital interest in QIAGEN as of Sep 16, 2026, via a mix of real and potential positions.Material DetailsContext by AI AnalystThis is a regulatory disclosure of a significant shareholder position, not…